Phibro Animal Health Corporation $PAHC Shares Sold by Jacobs Levy Equity Management Inc.

Key Points

• Jacobs Levy Equity Management Inc. reduced its stake in Phibro Animal Health Corporation by 2.5%, now owning 293,743 shares valued at approximately $6.27 million.
• Phibro Animal Health's stock price is currently at $41.19, with a market cap of $1.67 billion and a P/E ratio of 34.91.
• The company recently announced a quarterly dividend of $0.12, which will yield an annualized rate of 1.2%, with a current dividend payout ratio of 40.68%.

Jacobs Levy Equity Management Inc. cut its position in Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) by 2.5% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 293,743 shares of the company's stock after selling 7,430 shares during the quarter. Jacobs Levy Equity Management Inc. owned 0.73% of Phibro Animal Health worth $6,274,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Algert Global LLC boosted its stake in shares of Phibro Animal Health by 1.4% in the first quarter. Algert Global LLC now owns 97,612 shares of the company's stock valued at $2,085,000 after purchasing an additional 1,340 shares during the period. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of Phibro Animal Health in the fourth quarter valued at $29,000. National Bank of Canada FI purchased a new position in shares of Phibro Animal Health in the first quarter valued at $30,000. Price T Rowe Associates Inc. MD boosted its stake in shares of Phibro Animal Health by 9.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 17,668 shares of the company's stock valued at $372,000 after purchasing an additional 1,565 shares during the period. Finally, Lazard Asset Management LLC boosted its stake in shares of Phibro Animal Health by 2,739.7% in the fourth quarter. Lazard Asset Management LLC now owns 1,647 shares of the company's stock valued at $34,000 after purchasing an additional 1,589 shares during the period. 99.34% of the stock is currently owned by hedge funds and other institutional investors.

Phibro Animal Health Stock Performance

Shares of NASDAQ:PAHC traded down $1.57 on Friday, reaching $39.62. 238,815 shares of the company's stock were exchanged, compared to its average volume of 385,401. The firm has a market capitalization of $1.61 billion, a price-to-earnings ratio of 33.58, a PEG ratio of 1.18 and a beta of 0.88. Phibro Animal Health Corporation has a fifty-two week low of $16.16 and a fifty-two week high of $41.57. The business's 50-day moving average is $31.98 and its two-hundred day moving average is $25.55. The company has a quick ratio of 1.25, a current ratio of 2.76 and a debt-to-equity ratio of 2.46.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its earnings results on Wednesday, August 27th. The company reported $0.57 earnings per share for the quarter, topping analysts' consensus estimates of $0.52 by $0.05. The company had revenue of $378.70 million for the quarter, compared to analysts' expectations of $362.24 million. Phibro Animal Health had a net margin of 3.73% and a return on equity of 32.14%. Phibro Animal Health has set its FY 2026 guidance at 2.520-2.700 EPS. As a group, equities research analysts forecast that Phibro Animal Health Corporation will post 1.95 EPS for the current year.

Phibro Animal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 24th. Shareholders of record on Wednesday, September 3rd will be issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date of this dividend is Wednesday, September 3rd. Phibro Animal Health's dividend payout ratio is 40.68%.

Insider Buying and Selling at Phibro Animal Health

In related news, CEO Jack Bendheim sold 3,520 shares of the stock in a transaction dated Wednesday, September 10th. The shares were sold at an average price of $41.29, for a total value of $145,340.80. Following the sale, the chief executive officer owned 41,880 shares of the company's stock, valued at $1,729,225.20. This trade represents a 7.75% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 50.07% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of research analysts have commented on the stock. BNP Paribas upgraded shares of Phibro Animal Health to a "hold" rating in a research note on Monday, June 16th. Bank of America increased their price objective on shares of Phibro Animal Health from $19.00 to $27.00 and gave the company an "underperform" rating in a research note on Friday, August 29th. Morgan Stanley set a $34.00 price objective on shares of Phibro Animal Health in a research note on Thursday, August 28th. BNP Paribas Exane upgraded shares of Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price objective on the stock in a research note on Monday, June 16th. Finally, Zacks Research downgraded shares of Phibro Animal Health from a "strong-buy" rating to a "hold" rating in a research note on Thursday, August 28th. One analyst has rated the stock with a Buy rating, four have issued a Hold rating and two have assigned a Sell rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Reduce" and a consensus target price of $28.40.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.